Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivo

Neoplasia

Volumn 8, Issue 11, 2006, Pages 905-916

  Welman, Arkadiusz ^a   Cawthorne, Christopher ^a   Ponce Perez, Lourdes ^a   Barraclough, Jane ^a   Danson, Sarah ^a   Murray, Stephen ^a   Cummings, Jeff ^a   Allen, Terry D ^a   Dive, Caroline ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

c Src; Cell death; Colon cancer; Proliferation; Tet On

Indexed keywords

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN INDUCTION; XENOGRAFT;

EID: 33750737410     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06475     Document Type: Article

References (38)

1. Martin GS (2001). The hunting of the Src. Nat Rev Mol Cell Biol 2, 467-475.
2. Yeatman TJ (2004). A renaissance for SRC. Nat Rev Cancer 4, 470-480.
3. Thomas SM and Brugge JS (1997). Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13, 513-609.
4. Erpel Tand Courtneidge SA (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 7, 176-182.
5. Frame MC (2002). Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602, 114-130.
6. Summy JM and Gallick GE (2003). Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22, 337-358.
7. Russello SV and Shore SK (2004). SRC in human carcinogenesis. Front Biosci 9, 139-144.
8. Talamonti MS, Roh MS, Curley SA, and Gallick GE (1993). Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 91, 53-60.
9. Cartwright CA, Meisler AI, and Eckhart W (1990). Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87, 558-562.
10. Bolen JB, Veillette A, Schwartz AM, Deseau V, and Rosen N (1987). Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. Oncogene Res 1, 149-168.
11. Mao W, Irby R, Coppola D, Fu L, Wloch M, Turner J, Yu H, Garcia R, Jove R, and Yeatman TJ (1997). Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15, 3083-3090.
12. Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, and Gallick GE (2002). Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 94, 344-351.
13. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG, and Frame MC (2002). Src-induced de-regulation of E cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 4, 632-638.
14. Irby RB and Yeatman TJ (2002). Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res 62, 2669-2674.
15. Jones RJ, Avizienyte E, Wyke AW, Owens DW, Brunton VG, and Frame MC (2002). Elevated c-Src is linked to altered cell-matrix adhesion rather than proliferation in KM12C human colorectal cancer cells. Br J Cancer 87, 1128-1135.
16. Nam JS, Ino Y, Sakamoto M, and Hirohashi S (2002). Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res 8, 2430-2436.
17. Sakamoto M, Takamura M, Ino Y, Miura A, Genda T, and Hirohashi S (2001). Involvement of c-Src in carcinoma cell motility and metastasis. Jpn J Cancer Res 92, 941-946.
18. Cartwright CA, Eckhart W, Simon S, and Kaplan PL (1987). Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 49, 83-91.
19. Kmiecik TE and Shalloway D (1987). Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49, 65-73.
20. Riley D, Carragher NO, Frame MC, and Wyke JA (2001). The mechanism of cell cycle regulation by v-Src. Oncogene 20, 5941-5950.
21. Irby R, Mao W, Coppola D, Jove R, Gamero A, Cuthbertson D, Fujita DJ, and Yeatman TJ (1997). Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential. Cell Growth Differ 8, 1287-1295.
22. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P, and Hamelin R (2001). Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20, 5025-5032.
23. Welman A, Cawthorne C, Barraclough J, Smith N, Griffiths GJ, Cowen RL, Williams JC, Stratford IJ, and Dive C (2005). Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expression. J Cell Biochem 94, 1148-1162.
24. Welman A, Burger MM, and Hagmann J (2000). Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targeting and transformation. Oncogene 19, 4582-4591.
25. Reipert S, Bennion G, Hickman JA, and Allen TD (1999). Nucleolar segregation during apoptosis of haemopoietic stem cell line FDCP-Mix. Cell Death Differ 6, 334-341.
26. Kramer G, Erdal H, Mertens HJ, Nap M, Mauermann J, Steiner G, Marberger M, Biven K, Shoshan MC, and Linder S (2004). Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 64, 1751-1756.
27. Welman A, Barraclough J, and Dive C (2006). Generation of cells expressing improved doxycycline regulated reverse transcriptional transactivator rtTA2S-M2. Nat Protoc 1, 803-811.
28. Dehm S, Senger MA, and Bonham K (2001). SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett 487, 367-371.
29. Allgayer H, Wang H, Gallick GE, Crabtree A, Mazar A, Jones T, Kraker AJ, and Boyd DD (1999). Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J Biol Chem 274, 18428-18437.
30. Irby RB and Yeatman TJ (2000). Role of Src expression and activation in human cancer. Oncogene 19, 5636-5642.
31. Summy JM and Gallick GE (2006). Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res 12, 1398-1401.
32. Skinner J, Bounacer A, Bond JA, Haughton MF, deMicco C, and Wynford-Thomas D (2004). Opposing effects of mutant ras oncoprotein on human fibroblast and epithelial cell proliferation: implications for models of human tumorigenesis. Oncogene 23, 5994-5999.
33. Rangarajan A, Hong SJ, Gifford A, and Weinberg RA (2004). Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171-183.
34. Moasser MM, Srethapakdi M, Sachar KS, Kraker AJ, and Rosen N (1999). Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest. Cancer Res 59, 6145-6152.
35. Staley CA, Parikh NU, and Gallick GE (1997). Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Differ 8, 269-274.
36. Park J and Cartwright CA (1995). Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol Cell Biol 15, 2374-2382.
37. Parhamifar L, Jeppsson B, and Sjolander A (2005). Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells. Carcinogenesis 26, 1988-1998.
38. Smits VA and Medema RH (2001). Checking out the G(2)/M transition. Biochim Biophys Acta 1519, 1-12.